News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
A new study suggests that CAR T-cells, which are already used to treat certain blood cancers, may also be successful against solid tumors if combined with other immunotherapeutic approaches.
Lonza is ramping up operations for the start of extensive production of the Moderna COVID-19 vaccine at its plant in Visp, in south-west Switzerland.
Took a break over Christmas and New Year? Get up to speed with the latest developments in COVID-19 vaccines here.
The first dose of AstraZeneca’s COVID-19 vaccine has been administered in the UK this morning, after it was authorized for emergency supply last week.